AFYA 📈 Afya - Overview
Exchange: NASDAQ • Country: Brazil • Currency: USD • Type: Common Stock • ISIN: KYG011251066
AFYA: Medical Education, Online Courses, Health Services, Software Solutions
Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil. Web URL: https://www.afya.com.br
Additional Sources for AFYA Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
AFYA Stock Overview
Market Cap in USD | 1,387m |
Sector | Consumer Defensive |
Industry | Education & Training Services |
GiC Sub-Industry | Education Services |
IPO / Inception | 2019-07-19 |
AFYA Stock Ratings
Growth 5y | -56.3% |
Fundamental | 79.7% |
Dividend | - |
Rel. Strength Industry | -194 |
Analysts | 3.33/5 |
Fair Price Momentum | 12.96 USD |
Fair Price DCF | 492.46 USD |
AFYA Dividends
No Dividends PaidAFYA Growth Ratios
Growth Correlation 3m | -51.8% |
Growth Correlation 12m | -77.6% |
Growth Correlation 5y | -48.7% |
CAGR 5y | -10.85% |
CAGR/Mean DD 5y | -0.28 |
Sharpe Ratio 12m | -0.93 |
Alpha | -54.10 |
Beta | 0.97 |
Volatility | 39.70% |
Current Volume | 118.4k |
Average Volume 20d | 121.6k |
What is the price of AFYA stocks?
As of December 21, 2024, the stock is trading at USD 15.50 with a total of 118,410 shares traded.
Over the past week, the price has changed by -0.90%, over one month by -5.26%, over three months by -5.49% and over the past year by -27.60%.
As of December 21, 2024, the stock is trading at USD 15.50 with a total of 118,410 shares traded.
Over the past week, the price has changed by -0.90%, over one month by -5.26%, over three months by -5.49% and over the past year by -27.60%.
Is Afya a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Afya (NASDAQ:AFYA) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 79.66 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AFYA as of December 2024 is 12.96. This means that AFYA is currently overvalued and has a potential downside of -16.39%.
Yes, based on ValueRay Fundamental Analyses, Afya (NASDAQ:AFYA) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 79.66 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AFYA as of December 2024 is 12.96. This means that AFYA is currently overvalued and has a potential downside of -16.39%.
Is AFYA a buy, sell or hold?
Afya has received a consensus analysts rating of 3.33. Therefor, it is recommend to hold AFYA.
Afya has received a consensus analysts rating of 3.33. Therefor, it is recommend to hold AFYA.
- Strong Buy: 1
- Buy: 2
- Hold: 5
- Sell: 1
- Strong Sell: 0
What are the forecast for AFYA stock price target?
According to ValueRays Forecast Model, AFYA Afya will be worth about 14.2 in December 2025. The stock is currently trading at 15.50. This means that the stock has a potential downside of -8.52%.
According to ValueRays Forecast Model, AFYA Afya will be worth about 14.2 in December 2025. The stock is currently trading at 15.50. This means that the stock has a potential downside of -8.52%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 19.2 | 23.8% |
Analysts Target Price | 21.5 | 38.5% |
ValueRay Target Price | 14.2 | -8.5% |